Page last updated: 2024-10-31

moclobemide and Neuromuscular Diseases

moclobemide has been researched along with Neuromuscular Diseases in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research Excerpts

ExcerptRelevanceReference
"Serotonin syndrome is a potentially life-threatening complication of psychopharmacological drug therapy."2.40Serotonin syndrome and drug combinations: focus on MAOI and RIMA. ( Hilton, SE; Maradit, H; Möller, HJ, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hilton, SE1
Maradit, H1
Möller, HJ1

Reviews

1 review available for moclobemide and Neuromuscular Diseases

ArticleYear
Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
    European archives of psychiatry and clinical neuroscience, 1997, Volume: 247, Issue:3

    Topics: Autonomic Nervous System Diseases; Benzamides; Brain Stem; Drug Therapy, Combination; Humans; Moclob

1997